News

𝐓𝐮𝐫𝐧𝐢𝐧𝐠 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐮𝐫𝐠𝐞𝐧𝐜𝐲 𝐢𝐧𝐭𝐨 €24 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐨𝐟 𝐜𝐨𝐧𝐯𝐢𝐜𝐭𝐢𝐨𝐧 When we founded ShanX Medtech BV, it started with frustration: frustration with diagnostic delays, and with what patients and clinicians are forced to endure when bacterial infections aren't treated accurately in time. I'm grateful to build this next chapter with partners who recognize both the urgency and the scale of the problem, Borski Fund, NextGen Ventures, CbusineZ, Brabantse Ontwikkelings Maatschappij (BOM), Invest-NL, and our strategic angel partners and I thank them all for their trust and conviction. A huge shoutout to the people behind the organizations who actually made this possible: Bertrand Van Leersum, Simone Brummelhuis, Jen Roberts-Woods, Reinoud Pleij, Roel Dekkers, Peter Haasjes, Sanne van Erp, Joris Govers, Karel Stolper, Paul Vernooij, Koen Voskuil, Mats Wassink, Viktor Tsjebanov, Floris van Leeuwen, Ineke Cazander, and from our side Ardjan van der Linden, Henk Stapert, Alex van Belkum, the entire ShanX Medtech team throughout the years, and our first believer, Carmen van Vilsteren. Our gratitude extends to the European Commission Health Emergency Preparedness and Response Authority (DG HERA) EU in Emergencies and the European Health and Digital Executive Agency (HaDEA) for their trust to our solution.